Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial

অনুরূপ উপাদানগুলি

• Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children
  অনুযায়ী: Dicko, Alassane, অন্যান্য
  প্রকাশিত: (2013)
• Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study
  অনুযায়ী: Dicko, Alassane, অন্যান্য
  প্রকাশিত: (2015)
• Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life
  অনুযায়ী: Odusanya, Olumuyiwa O, অন্যান্য
  প্রকাশিত: (2014)
• Immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Taiwan
  অনুযায়ী: Tzou-Yien Lin, অন্যান্য
  প্রকাশিত: (2012-09-01)
• Effects of Vaccination with 10-Valent Pneumococcal Non-Typeable Haemophilus influenza Protein D Conjugate Vaccine (PHiD-CV) on the Nasopharyngeal Microbiome of Kenyan Toddlers.
  অনুযায়ী: Leah M Feazel, অন্যান্য
  প্রকাশিত: (2015-01-01)